Browse Studies — Arctuva

Observational

Feasibility Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) to Treat ICU Patients With Acute on Chronic Systolic Heart Failure With Worsening Renal Function Due to Cardiorenal Syndrome or Severe Right Ventricular Failure Awaiting Left Ventricular Assist Device Implantation

Cardiovascular disease is the leading cause of mortality in the US, accounting for 45% of all deaths. Chronic Heart Failure (CHF) is now understood to be a mul…

Acute on Chronic Systolic Congestive Heart FailureCardiorenal Syndrome

Estimated

~$10 – $7,500

Find your next paid study

DRAIN-HF: Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure